Home » Diabetes » GenWorks Health launches IVD tests for dengue & malaria, Health News, ET HealthWorld

GenWorks Health launches IVD tests for dengue & malaria, Health News, ET HealthWorld

Share Now :

Facebook
Twitter
WhatsApp
Telegram

New Delhi: GenWorks, a healthcare solutions provider, has recently announced the introduction of its In-Vitro Diagnostic (IVD) tests, which include Rapid Card test kits for Dengue and Malaria. The use of In-Vitro Diagnostic products for Dengue and Malaria are aimed at preventing, diagnosing, curing, and treating seasonal epidemics and mitigating their impact.

iScreen Malaria Card Antigen (Pf/Pv) by GenWorks is a visual lateral flow immunoassay designed for the qualitative and differential detection of P. falciparum specific histidine-rich protein-2 (Pf. HRP-2) and P. Vivax specific lactate dehydrogenase (pLDH) in human whole blood with 98.5 per cent sensitivity & 95 per cent specificity.

A blood specimen collected from the patient is applied to the sample pad on the test card along with buffer reagent. After 15 minutes, the presence of specific bands in the test card window indicates whether the patient is infected with Plasmodium Falciparum or Plasmodium Vivax of human malaria.

As per the company statement, iScreen Dengue NS1 by GenWorks offers an immunochromatographic one-step rapid card solution for qualitative early acute Dengue detection with NS1 antigen and differential detection of Dengue IgG & IgM antibodies in human serum.

  • Published On Jun 29, 2023 at 01:53 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App

Source link

madhuprayas
Author: madhuprayas

Leave a Comment

Related Post